Business Context and Reporting Period
This Form 8-K Current Report was filed by Supernus Pharmaceuticals, Inc. on June 17, 2015. The report addresses specific corporate events regarding the distribution of company stock by a major shareholder, New Enterprise Associates (NEA).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a shareholder distribution event and does not contain financial performance data.
Material Changes and Events
- Initial Announcement: On June 17, 2015, the Company announced that NEA distributed an aggregate of 3,921,000 shares of Supernus common stock to its partners, effective following the close of trading on June 15, 2015.
- Correction: Later on June 17, 2015, the Company issued a correction stating the accurate number of shares distributed by NEA was 3,000,000.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, or contingencies beyond the immediate event of the share distribution correction.
Key Facts for Investor Verification
- Verify the corrected share distribution volume of 3,000,000 shares from NEA to its partners.
- Confirm the effective date of the distribution was following the close of trading on June 15, 2015.
- Note the discrepancy between the initial press release (3,921,000 shares) and the corrected press release (3,000,000 shares) issued on the same day.